I Hate Dialysis Message Board

Dialysis Discussion => Dialysis: News Articles => Topic started by: okarol on May 10, 2010, 11:26:17 PM

Title: Mortality from Cancer among US Hemodialysis Patients, 1995–2005
Post by: okarol on May 10, 2010, 11:26:17 PM
In-Depth Topic Review

Mortality from Cancer among US Hemodialysis Patients, 1995–2005
Robert N. Foleya, b, Tricia L. Robertsa, Jiannong Liua, David T. Gilbertsona, Thomas J. Arnesona, Stephan Dunninga, Allan J. Collinsa, b

aChronic Disease Research Group, Minneapolis Medical Research Foundation, and
bDepartment of Medicine, University of Minnesota, Minneapolis, Minn., USA

Address of Corresponding Author

Am J Nephrol 2010;31:518-526 (DOI: 10.1159/000303754)

Abstract

Background/Aims: Concern has emerged that erythropoiesis-stimulating agents (ESAs) may decrease survival for cancer patients; many patients beginning dialysis have previous cancer diagnoses. As ESA doses have more than tripled in the USA since ESAs were introduced, we aimed to compare annual trends in cancer-specific mortality rates among incident maintenance hemodialysis patients. Methods: This national, retrospective, incident cohort study included 873,493 patients aged ≧20 years who initiated hemodialysis between 1995 and 2005. Cancer-specific mortality rates were adjusted for baseline characteristics, determined from the Centers for Medicare & Medicaid Services (CMS) Medical Evidence Report (form CMS-2728). Follow-up extended to December 31, 2006. Cause of death was ascertained from the Death Notification (form CMS-2746). Results: Crude first-year cancer-specific mortality rates, per 1,000 patient-years, 1995–2005, were as follows: 13.8, 13.7, 14.2, 14.9, 13.8, 15.4, 15.4, 16.5, 16.4, 15.8, 15.2. Mortality rates remained stable year to year within subsequent follow-up intervals; for the first and last annual cohorts, mortality rates by follow-up interval were: year 2, 9.1 and 8.7; year 3, 8.6 and 8.3; years 4–5, 7.9 and 6.8. Annual comparisons were similar after adjustment for patient characteristics at dialysis initiation. Conclusion: Cancer-specific mortality rates remained stable among US hemodialysis patients between 1995 and 2005.

Full article: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowFulltext&ArtikelNr=303754&Ausgabe=254143&ProduktNr=223979#abstract